Keros Therapeutics Inc (KROS)

Other Income/Expenses (Net)

$15.37M

TTM · Period ending: · USD

KROS logo

KROS Other Income/Expenses (Net)

Latest reported$15.37M
KROS TTM Other Income/Expenses (Net) (-$1.77M → $15.37M)
High-resolution chart · PNG

KROS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
15,371,000
20,043,000
24,328,000
27,561,000
26,582,000
24,865,000
23,780,000
22,464,000
20,603,000
19,253,000
16,949,000
12,979,000
13,606,000
13,236,000
10,111,000
7,794,000
3,189,000
-354,000
-360,000
2,330,000
2,380,000
2,618,000
1,124,000
-1,514,000
-2,649,000
-3,008,000
-1,773,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.